Register for Instructions and Zoom Meeting Link
Date: Wednesday, September 22, 1:00 pm
Program Presenter: Kenneth L. Londoner, MBA, Founder, Chief Executive Officer, Chairman, and Director
Kenneth L. Londoner, MBA, Founder, Chief Executive Officer, Chairman, and Director
BioSig’s founder and CEO, Ken Londoner, has a proven track record as a business entrepreneur, a biomedical executive, and an investment expert. His career highlights include founding Safe Port Holdings, which was sold for 6x investments; serving as EVP for New Cardio, a Silicon Valley cardiac software company; and founding Red Coat Capital Management, which grew from $2 million to more than $1 billion in assets.
About BioSig Technologies
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).
The Company’s first product, PURE EP™ System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.